Cannabidiol in humans-the quest for therapeutic targets. Zhornitsky S(1), Potvin S. Author information: (1)Multiple Sclerosis Clinic, Foothills. Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic. Cannabidiol (CBD), a major phytocannabinoid constituent of cannabis, is attracting growing attention in medicine for its anxiolytic, antipsychotic, antiemetic and.
Quest Targets Cannabidiol Therapeutic Humans—The in for
Dispensaries receive Responsible Vendor Certification by requiring specially trained bud tenders on staff to achieve a VFCF dispensary certificate. Look for the VFCF certified seal and you will find a dispensary providing verified cannabis strains and a staff with in-depth knowledge of their properties, strengths, and benefits.
Get the specific, approved strain of cannabis you need. No guessing, testing, or stressing. Ensure your experience is the same, uniform experience each time. The widespread prescription of opiate drugs to U. While the therapeutic use of cannabis has been proven to alleviate many symptoms of PTSD and chronic pain among many other symptoms and conditions , access is limited to those in a handful of states, and even in those rare places where sales are legal, in-depth education, and verification of the effects of specific cannabis strains is nearly nonexistent.
The VFCF cannabis DNA sequencing program puts the pieces of the cannabis puzzle together for doctors, dispensaries, and patients, creating a verified genotype of common strains of cannabis with a structured educational program for Veterans and highly trained bud tenders cannabis sommeliers , that includes verification of strain by sight and smell.
Veterans For Cannabis provides access to VFC Certified cannabis strains and also certified CBD oil that includes a dropper for dosing that has milliliters on the side of the dropper. Physicians most often shy away from cannabis recommendations because they do not understand how to advise the patient and there is no dosing protocol. Email address for updates. My profile My library Metrics Alerts.
Yale School of Medicine. International Clinical Psychopharmacology 26 4 , , Journal of clinical psychopharmacology 30 4 , , Canadian journal of psychiatry. Nonlinear dynamics, psychology, and life sciences 14 4 , , Multiple sclerosis and related disorders 5, , Progress in Neuro-Psychopharmacology and Biological Psychiatry 34 6 , , Articles 1—20 Show more. Cannabidiol in humans—the quest for therapeutic targets S Zhornitsky, S Potvin Pharmaceuticals 5 5 , , Oral versus long-acting injectable antipsychotics in the treatment of schizophrenia and special populations at risk for treatment nonadherence: Depression in multiple sclerosis: Multiple Sclerosis Journal 21 1 , , Dose-response and comparative efficacy and tolerability of quetiapine across psychiatric disorders: Psychiatry Research , , Antipsychotic-induced changes in blood levels of leptin in schizophrenia: Quetiapine fumarate for the treatment of multiple sclerosis:
Cannabidiol in Humans-The Quest for Therapeutic Targets.
Cannabidiol in Humans—The Quest for Therapeutic Targets. Post navigation. ← Previous Cannabis Study · Next Cannabis Study →. CBD = Cannabidiol. Cannabidiol in Humans-The Quest for Therapeutic Targets. Zhornitsky S, Potvin S. Pharmaceuticals (Basel). ; 5(5) PMID: Abstract. in Humans—The Quest for Therapeutic Targets. By Josh Sosnow, DVM 26Nov 0 Comment. Cannabidiol in Humans—The Quest for Therapeutic Targets.